FMC vs KROS · rev $1.63B vs rev $32.0K
FMC Corporation (FMC) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
FMC currently screens at market cap $1.50B. KROS currently screens at market cap $208.8M.
Not investment advice. Open the FMC and KROS stock pages for the full models.
Not investment advice.